Targeting Lineage-Specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small Molecule Inhibitor of P300/CBP

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0511
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

MITF Expression Predicts Therapeutic Vulnerability to P300 Inhibition in Human Melanoma

Cancer Research
Cancer ResearchOncology
2019English

Selective Inactivation of a Human Neuronal Silencing Phosphatase by a Small Molecule Inhibitor

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2011English

Targeting the Homologous Recombination Pathway by Small Molecule Modulators

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2014English

MOZ–TIF2-mediated Destruction of CBP/p300 Is Blocked by Calpain Inhibitor 2

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

A Small-Molecule E2F Inhibitor Blocks Growth in a Melanoma Culture Model

Cancer Research
Cancer ResearchOncology
2008English

Antitumor Effects of the Investigational Selective MEK Inhibitor TAK733 Against Cutaneous and Uveal Melanoma Cell Lines

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2012English

Tumor-Selective Targeting of Androgen Receptor Expression by Novel Small-Molecule Agents

2013English

The Depot-Specific and Essential Roles of CBP/p300 in Regulating Adipose Plasticity

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Lineage-Specific Control of TFIIH by MITF Determines Transcriptional Homeostasis and DNA Repair

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy